BOLT Market Cap History
Below is a table of the BOLT market cap history going back to 2/5/2021:

Date BOLT Market Cap
2/5/20211.02B
3/26/2021958.33M
8/6/2021475.81M

Also see: BOLT Shares Outstanding History
and BOLT YTD Return
BOLT Historical Market Cap:
-107.94% CAGR
BOLT Historical Market Cap: +-107.94% CAGR

Mouse over chart for data details
2/5/20213/26/20218/6/2021
Bolt Biotherapeutics is a clinical-stage immuno-oncology company, engages in the discovery, development, and commercialization of pharmaceutical products. Co. develops BDC-1001, a human epidermal growth factor receptor 2 (HER2) for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors. Co.'s preclinical stage product candidates include carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade; and myeloid modulators. We show 3 historical shares outstanding datapoints in our BOLT shares outstanding history coverage, used to compute BOLT market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing BOLT market cap history over the course of time is important for investors interested in comparing BOLT's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of BOLT versus a peer is one thing; comparing BOLT market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like BOLT can fluctuate over the course of history. With this page we aim to empower investors researching BOLT by allowing them to research the BOLT market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for BOLT:
BOLT SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Bolt Biotherapeutics (BOLT) is categorized under the Energy sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

BP Market Cap History
BPL Market Cap History
BRY Market Cap History
BSM Market Cap History
BTE Market Cap History
BWP Market Cap History
CAPL Market Cap History
CCLP Market Cap History
CDEV Market Cap History
CELP Market Cap History
More Energy companies »

 

BOLT Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.